Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders

Details for Australian Patent Application No. 2009203094 (hide)

Owner Xencor, Inc

Inventors Zalevsky, Jonathan; Steed, Paul Michael; Desjarlais, John R.; Szymkowski, David Edmund

Agent Davies Collison Cave

Pub. Number AU-A-2009203094

Parent 2004279895

Filing date 30 July 2009

Wipo publication date 20 August 2009

International Classifications

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 August 2009 Complete Application Filed

20 August 2009 Application Open to Public Inspection

  Published as AU-A-2009203094

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203095-Systems and methods for enhancing electronic communication security

2009203093-Process for Recovering Proteins from Crustacean Exoskeletons